BDX Stock Overview
BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer.
Notes are coming soon
BCAL Diagnostics Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.06|
|52 Week High||AU$0.15|
|52 Week Low||AU$0.059|
|1 Month Change||0%|
|3 Month Change||-9.09%|
|1 Year Change||-42.86%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-76.00%|
Recent News & Updates
|BDX||AU Biotechs||AU Market|
Return vs Industry: BDX underperformed the Australian Biotechs industry which returned 11.8% over the past year.
Return vs Market: BDX underperformed the Australian Market which returned 3.5% over the past year.
|BDX Average Weekly Movement||n/a|
|Biotechs Industry Average Movement||9.1%|
|Market Average Movement||8.5%|
|10% most volatile stocks in AU Market||15.7%|
|10% least volatile stocks in AU Market||3.5%|
Stable Share Price: Insufficient data to determine BDX's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine BDX's volatility change over the past year.
About the Company
BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient’s body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
BCAL Diagnostics Limited Fundamentals Summary
|BDX fundamental statistics|
Is BDX overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BDX income statement (TTM)|
|Cost of Revenue||AU$0|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.016|
|Net Profit Margin||-471.08%|
How did BDX perform over the long term?See historical performance and comparison